Fig. 1From: Discovery and validation of PZP as a novel serum biomarker for screening lung adenocarcinoma in type 2 diabetes mellitus patientsOverview of the study design. a Schematic diagram of serum specimens included in this study. b Schematic representation of the steps followed for the screening of the diagnostic proteins for LAC in T2DM patients (top) and the validated procedures (bottom)Back to article page